Prognostic value of a computer-aided diagnosis system involving bone scans among men treated with docetaxel for metastatic castration-resistant prostate cancer

被引：0
|
作者：
Koichi Uemura
Yasuhide Miyoshi
Takashi Kawahara
Shuko Yoneyama
Yusuke Hattori
Jun-ichi Teranishi
Keiichi Kondo
Masatoshi Moriyama
Shigeo Takebayashi
Yumiko Yokomizo
Masahiro Yao
Hiroji Uemura
Kazumi Noguchi
机构：
[1] Yokohama City University Medical Center,Department of Urology and Renal Transplantation
[2] Yokohama Municipal Citizen’s Hospital,Department of Urology
[3] Yokohama City University Medical Center,Department of Radiology
[4] Yokohama City University Graduate School of Medicine,Department of Urology
来源：
BMC Cancer | / 16卷
关键词：
Prostate cancer; Castration-resistant; Survival prediction; Bone scan index;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Phase Ib Study of Enzalutamide in Combination with Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer
    Morris, Michael J.
    Rathkopf, Dana E.
    Novotny, William
    Gibbons, Jacqueline A.
    Peterson, Amy C.
    Khondker, Zakaria
    Ouatas, Taoufik
    Scher, Howard I.
    Fleming, Mark T.
    CLINICAL CANCER RESEARCH, 2016, 22 (15) : 3774 - 3781
  • [32] Inflammatory factor-based prognostic risk stratification for patients with metastatic castration-resistant prostate cancer treated with docetaxel
    Shi, Xinyu
    Fan, Junjie
    Pei, Xinqi
    Wang, Yuzhao
    Guo, Guodong
    Yang, Tao
    Wang, Xinyang
    He, Dalin
    Li, Lei
    ANDROLOGIA, 2021, 53 (06)
  • [33] Prognostic value of bone scan index (BSI) using computer-aided diagnosis system for bone scans in hormone-naive prostate cancer patients with bone metastases
    Yoneyama, S.
    Miyoshi, Y.
    Moriyama, M.
    Uemura, K.
    Takebayashi, S.
    Uemura, H.
    Yao, M.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S482 - S482
  • [34] Integration of Bone and Computed Tomography Scans to Assess Bone Metastasis in Metastatic Castration-Resistant Prostate Cancer
    Parker, Scott J.
    Pond, Gregory R.
    Agarwal, Neeraj
    Alex, Anitha
    Heilbrun, Marta E.
    Sonpavde, Guru
    CLINICAL GENITOURINARY CANCER, 2017, 15 (01) : 53 - 59
  • [35] Re: Sarcopenia is a Poor Prognostic Factor of Castration-Resistant Prostate Cancer Treated with Docetaxel Therapy
    Griebling, Tomas L.
    JOURNAL OF UROLOGY, 2020, 203 (01): : 10 - 11
  • [36] Serum γ-Glutamyltransferase as a Prognostic Biomarker in Metastatic Castration-resistant Prostate Cancer Treated With Enzalutamide
    Takemura, Kosuke
    Ito, Masaya
    Nakanishi, Yasukazu
    Kataoka, Madoka
    Sakamoto, Kazumasa
    Suzuki, Hiroaki
    Tobisu, Ken-ichi
    Koga, Fumitaka
    ANTICANCER RESEARCH, 2019, 39 (10) : 5773 - 5780
  • [37] Prognostic value of novel inflammation index for patients with metastatic castration-resistant prostate cancer
    Yamada, Yasutaka
    Sakamoto, Shinichi
    Rii, Junryo
    Yamamoto, Satoshi
    Kamada, Shuhei
    Imamura, Yusuke
    Nakamura, Kazuyoshi
    Komiya, Akira
    Nakatsu, Hiroomi
    Ichikawa, Tomohiko
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [38] Survival by first-line therapy and prognostic group among men with metastatic castration-resistant prostate cancer
    Caram, Megan E. V.
    Kumbier, Kyle
    Tsao, Phoebe A.
    Burns, Jennifer
    Sparks, Jordan B.
    Stensland, Kristian D.
    Reichert, Zachery R.
    Alumkal, Joshi J.
    Hollenbeck, Brent K.
    Shahinian, Vahakn
    Tsodikov, Alexander
    Skolarus, Ted A.
    CANCER MEDICINE, 2024, 13 (12):
  • [39] Molecular Characterization of Enzalutamide-treated Bone Metastatic Castration-resistant Prostate Cancer
    Efstathiou, Eleni
    Titus, Mark
    Wen, Sijin
    Hoang, Anh
    Karlou, Maria
    Ashe, Robynne
    Tu, Shi Ming
    Aparicio, Ana
    Troncoso, Patricia
    Mohler, James
    Logothetis, Christopher J.
    EUROPEAN UROLOGY, 2015, 67 (01) : 53 - 60
  • [40] Evaluating the value of continuing docetaxel and prednisone (DP) beyond 10 cycles in men with metastatic castration-resistant prostate cancer (mCRPC).
    Pond, G. R.
    Armstrong, A. J.
    Wood, B. A.
    Brookes, M.
    Leopold, L. H.
    Berry, W. R.
    De Wit, R.
    Eisenberger, M. A.
    Tannock, I.
    Sonpavde, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345